Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease - Wikidata - awgldk - TriplyDB

Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease

Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease

http://www.wikidata.org/entity/Q29028321

about

Group B streptococcus immunisation during pregnancy for improving outcomes Vaccinations for pregnant women Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries From the microbiome to the central nervous system, an update on the epidemiology and pathogenesis of bacterial meningitis in childhood Prevention of neonatal group B streptococcus disease in the 21st century Obstetrical disease spectrum in China: an epidemiological study of 111,767 cases in 2011 Disease burden and antimicrobial resistance of invasive group B streptococcus among infants in China: a protocol for a national prospective observational study Group B Streptococcus β-hemolysin/cytolysin breaches maternal-fetal barriers to cause preterm birth and intrauterine fetal demise in vivo Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States.Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project.Neurological complications after neonatal bacteremia: the clinical characteristics, risk factors, and outcomes Preterm infants have deficient monocyte and lymphocyte cytokine responses to group B streptococcus Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.Sepsis from the gut: the enteric habitat of bacteria that cause late-onset neonatal bloodstream infections The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008.A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice.Emerging Infections Program Efforts to Address Health Equity Estimating the burden of invasive Group B Streptococcal disease in young infants in southern mainland China: an observational study Naturally occurring disseminated group B streptococcus infections in postnatal rats.Group B Streptococcus and Escherichia coli infections in the intensive care nursery in the era of intrapartum antibiotic prophylaxis.Antimicrobial peptide response to group B Streptococcus in human extraplacental membranes in culture.An update on vaccination against group B streptococcus.Long-term sequelae of childhood bacterial meningitis.Considerations in the pharmacologic treatment and prevention of neonatal sepsis.Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination.The ongoing quandary of defining the standard of care for neonates.Group B Streptococci serotype distribution in pregnant women in Ghana: assessment of potential coverage through future vaccines.Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development.Intrapartum antibiotic prophylaxis failure and group-B streptococcus early-onset disease.Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization.Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model.Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000-2010.Risk Factors for Late-Onset Group B Streptococcal Disease Before and After Implementation of Universal Screening and Intrapartum Antibiotic Prophylaxis.Preventing newborn infection with maternal immunization.The impact of group B streptococcus prophylaxis on late-onset neonatal infections.Codevelopment of Microbiota and Innate Immunity and the Risk for Group B Streptococcal Disease.Late Onset Streptococcus agalactiae Meningitis following Early Onset Septicemia: A Preventable Disease?Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models.

P2860

Q24186790-488C278B-04B7-47AB-8008-CC77E0FD725C Q26860740-B761E363-F887-4ABF-B87D-D075DBB9554B Q28075884-9316D544-6160-4451-9662-AAF44AE35468 Q29248091-582E24AC-028E-4FC3-A190-482E303B789D Q29399413-600D8C76-2EF0-4352-A6A1-0457A5858EE9 Q33422599-DF07D304-EA84-4D36-823B-E16617EF6F3E Q33750103-58A05A0F-4444-4F41-96CD-0FC7538A2F72 Q33883219-14E96835-AE52-4D1C-8E54-04361D376550 Q34082651-1CB8750F-1932-40BB-8C8E-51B6DB6C103C Q34112608-911A3726-9B9E-4BD4-889A-9A8F5AF2C12D Q34120642-2D2B8783-7BFC-48FE-B919-EEE5E7588CC4 Q34252808-5BC007A7-7B35-4BD2-A8B8-DE470A3324B9 Q34443702-AFBA48EC-8BE3-4B18-B3A8-FE606F6173A2 Q34740184-78C3E4C2-88CA-48C0-A719-BCCFD5399B97 Q35122775-FCB039D4-F63C-4C5A-BE40-5E6C830725DD Q35125020-11FC3264-1CA5-441A-8545-029D8EA146DE Q35349957-33715B04-F7C4-404D-B787-1B969C793380 Q35870249-ADB63942-E51F-46F9-8B3C-23129595EDE4 Q35997510-4FFDA2A3-4292-45F8-84FE-0CF8A14F484E Q36183228-8E5EA6BF-5DB3-4C71-BD38-36E787982A33 Q36595438-7411AA8B-AC08-4BCA-9D50-99103E0764BC Q36609479-036E6F82-D14C-4123-A235-7F5F3D1AE310 Q36877367-A756FF44-28AC-435D-AEFE-F2C5454A8414 Q37878487-CB34A393-5FF1-4081-B30E-7E5B6A7C03A8 Q38094111-1196EDB2-0D16-4E6A-B7D4-6475DBC97CE4 Q38161849-C9D6EF05-6B89-4897-B277-AD789382A778 Q38570903-70AC0284-48B1-4DFB-9BD5-8691DCD7FD7C Q38814319-F6D94348-C09C-48FC-B168-76153E313225 Q38973082-10E0793A-111D-48EF-A8DF-19D43E50A3EA Q39548543-90F77022-1367-46C3-9C51-26CE40C1CBFF Q40320047-91AED5B9-2781-49FC-9815-2F3118E65317 Q40344808-78136C9E-0347-480E-BCD6-9A6BDD1A86CF Q40410171-38380F4D-2C82-44FA-9292-B58757AFC84F Q40513651-782A83E4-1727-4B09-B86F-BA3124BD0059 Q41186429-A42838F7-9ADE-4C3C-B3D7-134FF2901A46 Q42253830-A3B48621-9170-4FF3-8BB8-D2938B1A7337 Q43870067-D0998B78-3E66-4DA5-8CF7-8673DAED3A26 Q46247272-32B3180A-FE6C-4D6A-A465-382FB80BF948 Q47134871-D3B2B732-4871-4528-AB06-9FFB22151CA3 Q50129993-FE81ECFC-B977-4449-89E9-1926DC8F724D

P2860

Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease

http://www.wikidata.org/entity/Q29028321

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Revisiting the Need for Vaccin ...... Group B Streptococcal Disease

@ast

Revisiting the Need for Vaccin ...... Group B Streptococcal Disease

@en

type

label

Revisiting the Need for Vaccin ...... Group B Streptococcal Disease

@ast

Revisiting the Need for Vaccin ...... Group B Streptococcal Disease

@en

prefLabel

Revisiting the Need for Vaccin ...... Group B Streptococcal Disease

@ast

Revisiting the Need for Vaccin ...... Group B Streptococcal Disease

@en

P1433

Q29028321-68809A18-5979-4248-B237-2F8C7F68819A

P1476

Q29028321-CF224EBB-1B8E-435D-9439-3A879EDE6C97

P2093

Q29028321-02A996BA-F4F0-4646-A934-E9717A233082

Q29028321-05BE2324-026D-4843-BBA9-431E19A61729

Q29028321-20A317E6-F8C3-45D8-9B72-62B46BC2DCA6

Q29028321-26090B51-176A-49C1-B24A-C62E6FA894DF

Q29028321-38100DEE-DB4E-4A9E-996E-14605D4DC0B1

Q29028321-5D4F3D6E-E868-4C6D-9A34-9B4A37AFC51B

Q29028321-6692FB58-E4BD-4390-8122-2CBDD021AD92

Q29028321-6ADF70BF-0FE7-4252-B832-AEE751B12F87

Q29028321-8C990F4A-BD66-4E4E-9DD0-71E077E60294

Q29028321-93F8CE1E-8CC5-4D5C-88C0-F863E42B78C5

P304

Q29028321-F4A3D987-01B2-4F60-8ECD-B84462962342

P31

Q29028321-5C294198-B21B-4D22-9DB1-28AE8CC347E9

P3181

Q29028321-BF667C7B-DE4E-44D2-AB63-9FB6E48F141A

P356

Q29028321-13FE0FA5-8B37-42CD-B08A-F6CA89CF7A4E

P433

Q29028321-9F0720F7-7C76-4BA1-963A-89E3EEE95766

P478

Q29028321-38126408-4B8A-49EA-BFEC-4E6C267BEEC4

P50

Q29028321-3489FCAF-F633-4D37-BA6B-B8601650AF20

Q29028321-9BB73EDB-53A5-469E-8102-F53F3564FE75

P577

Q29028321-8021316E-F34E-477B-8206-2A7E4105B958

P698

Q29028321-14838D23-6A92-4B4E-87DB-44891B7DF60B

P3181

P356

INF.0B013E318180B3B9

P1433

Pediatric Infectious Disease Journal

P1476

Revisiting the Need for Vaccin ...... Group B Streptococcal Disease

@en

P2093

Allen Craig

http://www.w3.org/2001/XMLSchema#string

Ann Thomas

http://www.w3.org/2001/XMLSchema#string

Bernadette A. Albanese

http://www.w3.org/2001/XMLSchema#string

Hannah T. Jordan

http://www.w3.org/2001/XMLSchema#string

Janet Mohle-Boetani

http://www.w3.org/2001/XMLSchema#string

Kenneth Gershman

http://www.w3.org/2001/XMLSchema#string

Lee H. Harrison

http://www.w3.org/2001/XMLSchema#string

Monica M. Farley

http://www.w3.org/2001/XMLSchema#string

Shelley Zansky

http://www.w3.org/2001/XMLSchema#string

Stephanie J. Schrag

http://www.w3.org/2001/XMLSchema#string

P304

1057-1064

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3376583

http://www.w3.org/2001/XMLSchema#string

P356

10.1097/INF.0B013E318180B3B9

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

William Schaffner

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18989238

http://www.w3.org/2001/XMLSchema#string